• Allergan, Richter Announce Positive Results in Cariprazine Study americanpharmaceuticalreview
    December 19, 2017
    Allergan and Gedeon Richter announced positive topline results for a phase 3 study of cariprazine for the treatment of adults with major depressive episodes associated with bipolar I disorder (bipolar I depression).
PharmaSources Customer Service